Leica Biosystems and Bio-Techne have launched the CE-IVD marked RNAscope In Situ Hybridization Detection Kit for automation on the BOND-III platform in Europe.
Bio-Techne’s RNAscope together with Leica’s platform will enable pathologists to access the leading applications to support their diagnostics labs.
The technology improves on traditional ISH methodologies through higher target sensitivity and specificity. It detects RNA expression patterns and localisation at the single-cell level with spatial and morphologic context.
Bio-Techne Diagnostics and Genomics Segment president Kim Kelderman said: “We are excited to expand our Leica partnership with the launch of our CE-IVD marked detection kit in Europe.